Home › Carpal Tunnel Syndrome › NCT03867539

Exparel and Education to Avoid Opioids After Carpal Tunnel Release

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* carpal tunnel syndrome diagnosed either by physical exam or EMG
* age \>18.

Exclusion Criteria:

* allergy to bupivacaine
* pre-operative opioid usage within the last six months
* patients allergic to Percocet or acetaminophen
* patients taking tricyclic antidepressants (interaction with bupivacaine)
* vulnerable populations (prisoners or pregnant women)

About the study

This trial seeks to use the long acting local anesthetic Exparel, in conjunction with opioid education, to attempt to avoid any post-operative opioid use following carpal tunnel surgery. This group will be compared with a "standard" group that receives non-liposomal bupivacaine, opioid education, and opioids.

What is being tested

• Differing pain management strategy (drug)

Sponsor: Kettering Health Network · Participants: 64 · Started: Feb 15, 2019

Contact the study team

• Ronald Buczek, DO · Phone: 937-439-6483

Official record on ClinicalTrials.gov — NCT03867539

Locations in the U.S.

Conditions

• Carpal Tunnel Syndrome

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.